YOLFTbeta
ALPHA

ALPHA

0303 · KLSE · Healthcare / Medical Care Facilities

0.28MYR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.28
Open0.28
Day Range0.28 – 0.28
52-Week Range0.2293 – 0.3307
Volume338.40K
Market Cap1.23B
P/E (TTM)25.50
Forward P/E18.45
EPS0.01
Dividend Yield4.71%
Beta0.09
50-Day Avg0.2607
200-Day Avg0.2656

About

Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and savior sibling program; preimplantation genetic testing; implantation optimisation; sperm sorting; and egg freezing, embryo freezing and cryo-storage, laparoscopic surgery, hysteroscopic surgery, 4D ultrasound scanning, and artificial intelligence-enhanced embryo selection services. It also provides various diagnostics, testing and screening procedures; cryopreservation of eggs and sperms; medical consultants; fertility, gynecological, and obstetric treatment; and other women-related healthcare and medical services. In addition, the company operates women's specialist centers. Alpha IVF Group Berhad was founded in 2011 and is based in Petaling Jaya, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEODr. Soon Soo Lee MBBS
  • Employees198
  • HeadquartersEncorp Strand Mall, Petaling Jaya, Malaysia, 47810, Malaysia
  • Websitehttps://alphaivfgroup.com

Leadership

  • Dr. Soon Soo Lee MBBSGroup MD, Medical Director of Alpha KL & Non-Independent Executive Director · b. 1958
  • Dr. Peng Wah NgMedical Director of Genesis & Non-Independent Executive Director · b. 1955
  • Mr. Hon Lung LiewGroup Chief Financial Officer · b. 1986
  • Ms. Yee Man KwanGroup Chief Operating Officer · b. 1977
  • Ms. Yun Xin LimGroup Scientific Director · b. 1983
  • Mr. Kay Pau TanGroup Chief Corporate Officer · b. 1989
  • Sue Ching LeongCompany Secretary
  • Ms. Soon Ai LeeDirector of Operations - Alpha International Women's Specialists (Singapore) Pte. Ltd · b. 1953

Financials

Income Statement

Currency: MYR2020-05-312021-05-312022-05-312023-05-312024-05-312025-05-312026-05-31
Total Revenue68.95M62.06M91.09M137.48M167.59M176.84M198.59M
Growth (%)--9.99%+46.78%+50.92%+21.90%+5.52%+12.30%
Cost of Revenue38.74M34.63M44.57M60.84M70.21M69.69M79.62M
Gross Profit30.21M27.43M46.52M76.64M97.37M107.16M118.96M
Gross Margin43.81%44.20%51.07%55.75%58.10%60.59%59.90%
Operating Expense25.75M12.72M15.24M20.96M24.49M33.06M43.11M
Operating Income4.47M14.71M31.29M55.68M72.88M74.10M75.85M
Operating Margin6.48%23.70%34.35%40.50%43.49%41.90%38.19%
EBITDA---75.22M79.13M83.01M85.48M
EBITDA Margin---54.72%47.22%46.94%43.04%
Net Income2.47M-3.08M14.31M53.24M52.93M57.45M53.63M
Net Income Margin3.58%-4.96%15.70%38.73%31.59%32.49%27.01%
Interest Expense1.13M1.40M1.35M1.02M811.00K1.08M1.60M
Interest Expense % of Total Revenue1.64%2.25%1.48%0.74%0.48%0.61%0.81%

Balance Sheet

Currency: MYR2020-05-312021-05-312022-05-312023-05-312024-05-312025-05-312026-05-31
Total Assets74.96M92.23M107.08M95.85M228.27M250.80M254.90M
Total Liabilities46.61M43.66M48.11M41.30M38.49M46.66M59.27M
Total Equity16.90M33.71M40.47M51.60M187.43M198.04M189.74M
Cash1.76M8.23M19.34M19.95M22.91M34.43M37.01M
Net Debt13.52M6.23M-----

Cash Flow

Currency: MYR2020-05-312021-05-312022-05-312023-05-312024-05-312025-05-312026-05-31
Operating Cash Flow23.63M11.21M34.32M60.61M59.05M54.91M66.73M
Capital Expenditure12.00M356.01K394.72K866.23K8.41M7.32M27.69M
Free Cash Flow11.63M10.85M33.92M59.74M50.64M47.59M39.05M
Dividends Paid----31.38M46.17M48.52M
FCF to OCF49.23%96.82%98.85%98.57%85.75%86.67%58.51%
Dividend Paid to FCF----61.97%97.01%124.25%

Earnings

Report DateJul 17, 2024Oct 21, 2024Jan 21, 2025Apr 22, 2025Jul 14, 2025Oct 17, 2025Apr 14, 2026Jul 23, 2026
EPS Estimate--------
EPS Actual0.000.000.000.000.000.000.000.00
Surprise--------
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap1.23B
Enterprise Value1.06B
Trailing P/E25.50
Forward P/E18.45
Price / Sales6.21
Price / Book6.12
EPS0.01
Book Value0.039
Revenue (TTM)198.59M
Gross Profit (TTM)118.96M
EBITDA74.94M
Profit Margin27.01%
Operating Margin35.45%
Return on Equity26.64%
Return on Assets17.18%
Shares Outstanding4.84B
Shares Float1.13B
Beta0.09
Dividend Yield4.71%
Dividend Rate0.01
Payout Ratio2.04%

Dividends

20261×
0.01Mar 18, 2026
20251×
0.01Aug 8, 2025
20242×
0.01Dec 17, 20240.00Jul 30, 2024